Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -21.86% | 32.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.86% | 32.03% | |||
| Cost of Revenue | -4.18% | -9.03% | |||
| Gross Profit | -38.73% | 131.75% | |||
| SG&A Expenses | 10.24% | -4.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.22% | -6.30% | |||
| Operating Income | -2,200.28% | 103.67% | |||
| Income Before Tax | -233.98% | 89.64% | |||
| Income Tax Expenses | -13.25% | -2,616.67% | |||
| Earnings from Continuing Operations | -239.20% | 89.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 248.52% | -90.33% | |||
| Net Income | -232.60% | 89.54% | |||
| EBIT | -2,200.28% | 103.67% | |||
| EBITDA | -127.62% | 268.32% | |||
| EPS Basic | -229.02% | 89.63% | |||
| Normalized Basic EPS | -788.00% | -97.08% | |||
| EPS Diluted | -229.02% | 89.63% | |||
| Normalized Diluted EPS | -788.00% | -97.08% | |||
| Average Basic Shares Outstanding | 1.07% | 0.93% | |||
| Average Diluted Shares Outstanding | 1.07% | 0.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||